Global Deep Transcranial Magnetic Stimulation (DTMS) Device Market Overview:
Depression has become a common illness worldwide, the growing number of cases people suffering from depression is booming the demand of DTMS devices in the market. Deep transcranial magnetic stimulation device used for the treatment of people suffering from depression. It uses a technique where pulsed magnetic fields are generated by a coil placed on the scalp. According to the world health organization, more than 264 million people are affected by dispersion and it is different from usual mood changes and short live emotional responses to challenges in daily life routine. A moreover growing number of major depressive disorder (MDD) and Obsessive-Compulsive Disorder (OCD) is a key driving factor of growth in the market. Some of the key players profiled in the study are Dr. Langer Medical GmbH (Germany), MAG & More GmbH (Germany), Remed (United States), Axilum Robotics (France), Nexstim Plc (Finland), The Magstim Company Limited (United Kingdom), Neuronetics (United States), Salience TMS Neuro Solutions (United States), Mag Venture (United States) and eNeura Inc. (United States).
On the basis of geography, the market of Deep Transcranial Magnetic Stimulation (DTMS) Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Deep Transcranial Magnetic Stimulation (DTMS) Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Number Of Mental Disorders Cases Across The Globe Is Key Driving Factor Of Growth
- Increasing Number Of Patients And Healthcare Providers Attesting DTMS Success
- High Cost Associated with DTMS devices
- The Growing Scope Of The DTMS Devices And Stimulation Technique In Diagnosis And To Treat Neurological Disorders Creating The Growth Opportunities
- Key Competition Between Manufacturers
Major Market Developments:
In March 2019 Brain Way Ltd Israel based company has announced that it has been acquired and extensive multi-channel transcranial magnetic stimulation patent portfolio from TMS innovation. In addition, it also entered into an exclusive option agreement with Standford University for the permission of multichannel TMS related patents.
In May 2019 France based company Axilum Robotics proclaim FDA 510(k) Clearance for TMS-Cobot, it is an aids in the precise implementation of transcranial magnetic stimulation. TMS robot is the first robot used to assist health care professionals in delivering DTMS.
New Entrants/Investors, Analysts and Strategic Business Planners, Deep Transcranial Magnetic Stimulation (DTMS) Device Manufacturer, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
Major Objectives Focused through this Study
To define, describe, and forecast the Global Deep Transcranial Magnetic Stimulation (DTMS) Device market on the basis of product [Deep Transcranial Magnetic Stimulator (dTMS), Repetitive Transcranial Magnetic Stimulator (rTMS) and Others] , application [Depression, Parkinsonís Disease, Epilepsy, Alzheimerís Disease and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Deep Transcranial Magnetic Stimulation (DTMS) Device market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Deep Transcranial Magnetic Stimulation (DTMS) Device industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are BrainsWay (Israel).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Deep Transcranial Magnetic Stimulation (DTMS) Device market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.